Vaibhav Narayan

Title: Innovations by Vaibhav Narayan

Introduction

Vaibhav Narayan is an accomplished inventor based in Princeton, NJ, known for his significant contributions to the field of cognitive health. With a total of three patents to his name, Narayan has focused on developing innovative methods for detecting cognitive decline and managing schizophrenia.

Latest Patents

One of Narayan's latest patents is titled "System and method for detecting cognitive decline using speech analysis." This invention outlines a classification system that detects cognitive decline in subjects based on their speech samples. The system is trained using audio recordings from both normal patients and those experiencing cognitive decline. It generates an ensemble classifier that utilizes multiple machine-learning classifiers to identify whether a sample corresponds to a normal or cognitive decline patient.

Another notable patent is "Methods of identifying schizophrenia patients at risk for relapse." This invention provides methods for early detection of relapse in schizophrenia patients by monitoring specific symptoms and biomarkers. The severity of symptoms can be assessed using the Positive and Negative Syndrome Scale (PANSS) parameters. These methods aim to facilitate early intervention to reduce or prevent relapse in patients suffering from schizophrenia.

Career Highlights

Vaibhav Narayan is currently employed at Janssen Pharmaceutica NV, where he continues to innovate in the field of mental health. His work focuses on leveraging technology to improve patient outcomes and enhance the understanding of cognitive disorders.

Collaborations

Narayan collaborates with esteemed colleagues such as Srinivasan Vairavan and Dai Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Vaibhav Narayan's work exemplifies the intersection of technology and healthcare, particularly in the realm of cognitive health. His patents reflect a commitment to improving the lives of individuals affected by cognitive decline and schizophrenia.